pre-ipo
Stage
About
Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing transformative therapies targeting urologic conditions.
Explore Urovant Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.